title: Investigation of a one-time phenol application for pilonidal disease.
abstract: OBJECTIVE
  To investigate wound healing rates and postoperative recovery of patients after a one-time phenol application for pilonidal disease.
  
  
  METHODS
  A total 30 consecutive patients with chronic pilonidal disease ranging from midline to complex sinuses were enrolled in the study. No preoperative laboratory examinations or bowel preparation were required. No antibiotic prophylaxis or sedation was used. A small incision was made on the midline and hair/debris in the sinuses was removed. A cotton swab with saturated phenol was moved into the cavity and the phenol was left for 2 min. No special dressing was necessary and patients left the hospital immediately afterwards. Patients filled out a daily questionnaire for 7 days. We did not intervene in the wounds with a second phenol application or curettage during the observation period. Wounds were inspected at weekly intervals for 2 months.
  
  
  RESULTS
  At the end of the third day, 97% of the patients were pain-free and 100% of the patients were free from analgesics. Time off work was 2 days for most patients (93.3%). Twenty-eight (93.3%) patients were satisfied with the procedure, they found it easy and painless and suggested the procedure to other patients. Twenty-five (83%) patients were asymptomatic at the end of 2 months' observation and the remaining 5 patients had unhealed sinuses. Mean time for wound healing was 25 days (range 10-63 days). There were 4 recurrences after a mean of 14 months' follow-up and the overall success rate was 70%.
  
  
  CONCLUSIONS
  A one-time phenol application was an effective treatment for pilonidal disease with acceptable wound healing rates, less postoperative pain and less time off work. Hence it can be an alternative treatment modality.
authors.affiliation: Department of General Surgery, Inonu University, and Beydagi State Hospital, Malatya, Turkey. cuneytkayaalp@hotmail.com
authors.forename: Cuneyt
authors.initials: C
authors.lastname: Kayaalp
authors.forename: Aydemir
authors.initials: A
authors.lastname: Olmez
authors.forename: Cemalettin
authors.initials: C
authors.lastname: Aydin
authors.forename: Turgut
authors.initials: T
authors.lastname: Piskin
authors.forename: Latif
authors.initials: L
authors.lastname: Kahraman
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D010146:Pain / Q000139:chemically induced; D019800:Phenol / Q000009:adverse effects / Q000627:therapeutic use*; D010864:Pilonidal Sinus / Q000628:therapy*; D012597:Sclerosing Solutions / Q000009:adverse effects / Q000627:therapeutic use*; D014945:Wound Healing / Q000187:drug effects; D055815:Young Adult
chemical_list: D012597:Sclerosing Solutions; D019800:Phenol